DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

TFT Halls & Rooms

2013 年 11 月 06 日 11:00 上午 - 2013 年 11 月 06 日 12:45 下午

TFT Building, 3-6-11 Ariake, , Koto-ku,, Tokyo, 135-8071 Japan

#6: Control Strategy for Drug Substance Based on ICH M7 and Q11

讲演嘉宾

Haruhiro  Okuda, PHD

Haruhiro Okuda, PHD

Deputy Director General, National Institute of Health Sciences, Japan

Dr. Haruhiro Okuda is Honorary Director General of National Institute of Health Sciences (NIHS). After obtaining Ph.D degree in medicinal chemistry from University of Tokyo, he joined the Pharmaceuticals and Medical Devices Evaluation Center, the predecessor of PMDA. From 2002 to 2020, he worked for NIHS, and served as Head of Division of Organic Chemistry, Head of Division of Drugs and Director-General of NIHS. He worked to harmonize regulation on quality of chemical drugs for over 10 years as a member of ICH. He also works to harmonize Pharmacopoeias of Japan, EU, and the USA as a PDG (Pharmacopoeia Discussion Group) member. He has now worked for Pharmaceutical and Medical Device Regulatory Science Society of Japan.

Yukio  Aso, PHD

Yukio Aso, PHD

, National Institute of Health Sciences, Japan

Kazunori  Takagi, PHD

Kazunori Takagi, PHD

Deputy Review Director, Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。